Trojan Bio is a preclinical immunotherapy company developing a novel class of therapeutic antibodies for the treatment of a variety of cancers. The company’s Trojan antibodies integrate viral peptides to efficiently activate the immune system for cancer eradication. Trojan Bio specific antibody is composed of 2 modules - Cancer targeting module and a Viral immunity activation module. It targets cancer cells and label them as virally infected cells. The company is harnessing the powerful anti-viral immunity to fight a variety of cancers.